Reuters logo
BRIEF-Fate Therapeutics to amend and restate loan and security agreement
July 14, 2017 / 8:26 PM / 3 months ago

BRIEF-Fate Therapeutics to amend and restate loan and security agreement

July 14 (Reuters) - Fate Therapeutics Inc

* Fate Therapeutics Inc - on July 14, 2017 co entered into first amendment to amended and restated loan and security agreement - SEC filing

* Fate Therapeutics - SVB loan amendment amends certain amended and restated loan and security agreement between company and bank, dated as of July 30, 2014

* Fate Therapeutics Inc - term loan matures on January 1, 2022

* Fate Therapeutics - pursuant to SVB loan amendment, bank extended an additional term loan to company on July 14, 2017 in principal amount of $15 million

* Fate Therapeutics Inc - from August 1, 2017 through January 1, 2019 company is required to make monthly payments of interest only Source text for Eikon: (bit.ly/2tSfwUO) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below